MELISSA FENSTERSTOCK

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

NAYA Biosciences, Inc.

Filing Date Source Excerpt
2025-02-11 "Ms. Fensterstock... focuses on frontier technologies, helping early-stage companies translate innovations from academic settings to commercial scale... As an Expert-in-residence at Digitalis Commons, Ms. Fensterstock advises ARPA-H innovators working on early-stage health technologies."

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-26